Antitumor effects of high-temperature hyperthermia on a glioma rat model

Oncology Letters

Volumn 7, Issue 4, 2014, Pages 1007-1010

  Takagi, Hidefumi ^a,b   Azuma, Kazuo ^c   Tsuka, Takeshi ^c   Imagawa, Tomohiro ^c   Osaki, Tomohiro ^c   Okamoto, Yoshiharu ^c  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b Takagi Animal Clinic   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

Author keywords

Apoptosis; Glioma; High temperature hyperthermia; Ki 67

Indexed keywords

KI 67 ANTIGEN;

ABLATION DEVICE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GLIOMA; HYPERTHERMIC THERAPY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; NICK END LABELING; NONHUMAN; RAT; TUMOR GROWTH; TUMOR VOLUME;

EID: 84896709577     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1852     Document Type: Article

References (27)

1. Soares PI, Ferreira IM, Igreja RA, Novo CM and Borges JP: Application of hyperthermia for cancer treatment: recent patents review. Recent Pat Anticancer Drug Discov 7: 64-73, 2012.
2. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R and Schlag PM: Hyperthermia in combined treatment of cancer. Lancet Oncol 3: 487-497, 2002.
3. Falk MH and Issels RD: Hyperthermia in oncology. Int J Hyperthermia 17: 1-18, 2001.
4. Ross MI: Current status of hyperthermic limb perfusion for in-transit melanoma. Int J Hyperthermia 24: 205-217, 2008.
5. Pennacchioli E, Fiore M and Gronchi A: Hyperthermia as an adjunctive treatment for soft-tissue sarcoma. Expert Rev Anticancer Ther 9: 199-210, 2009.
6. Harmon BV, Takano YS, Winterford CM and Gobé GC: The role of apoptosis in the response of cells and tumours to mild hyperthermia. Int J Radiat Biol 59: 489-501, 1991.
7. Horsman MR: Tissue physiology and the response to heat. Int J Hyperthermia 22: 197-203, 2006.
8. Diederich CJ: Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation. Int J Hyperthermia 21: 745-753, 2005.
9. Roti Roti JL: Cellular responses to hyperthermia (40-46 degrees C): cell killing and molecular events. Int J Hyperthermia 24: 3-15, 2008.
10. den Brok MH, Sutmuller RP, van der Voort R, Bennink EJ, Figdor CG, Ruers TJ and Adema GJ: In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 64: 4024-4029, 2004.
11. Baronzio G, Gramaglia A and Fiorentini G: Hyperthermia and immunity. A brief overview. In Vivo 20: 689-695, 2006.
12. Zerbini A, Pilli M, Penna A, Pelosi G, Schianchi C, Molinari A, Schivazappa S, Zibera C, Fagnoni FF, Ferrari C and Missale G: Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 66: 1139-1146, 2006.
13. Mukhopadhaya A, Mendecki J, Dong X, Liu L, Kalnicki S, Garg M, Alfieri A and Guha C: Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity. Cancer Res 67: 7798-7806, 2007.
14. Zhang HG, Mehta K, Cohen P and Guha C: Hyperthermia on immune regulation: a temperature's story. Cancer Lett 271: 191-204, 2008.
15. Moroz P, Jones SK and Gray BN: Magnetically mediated hyperthermia: current status and future directions. Int J Hyperthermia 18: 267-284, 2002.
16. Rees JH: Diagnosis and treatment in neuro-oncology: an oncological perspective. Br J Radiol 84: S82-S89, 2011.
17. Fiorentini G, Giovanis P, Rossi S, Dentico P, Paola R, Turrisi G and Bernardeschi P: A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia. In Vivo 20: 721-724, 2006.
18. Bidwell GL 3rd, Perkins E, Hughes J, Khan M, James JR and Raucher D: Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model. PLoS One 8: e55104, 2013.
19. Wang DC, Zhang Y, Chen HY, Li XL, Qin LJ, Li YJ, Zhang HY and Wang S: Hyperthermia promotes apoptosis and suppresses invasion in C6 rat glioma cells. Asian Pac J Cancer Prev 13: 3239-3245, 2012.
20. Stojkovic R and Radacic M: Cell killing of melanoma B16 in vivo by hyperthermia and cytotoxins. Int J Hyperthermia 18: 62-71, 2002.
21. Ito A, Fujioka M, Yoshida T, et al: 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer Sci 98: 424-430, 2007.
22. Haen SP, Pereira PL, Salih HR, Rammensee HG and Gouttefangeas C: More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol: 160250, 2011.
23. Xia QS, Liu X, Xu B, Zhao TD, Li HY, Chen ZH, Xiang Q, Geng CY, Pan L, Hu RL, et al: Feasibility study of high-temperature thermoseed inductive hyperthermia in melanoma treatment. Oncol Rep 25: 953-962, 2011.
24. Li DY, Tang YP, Zhao LY, Geng CY and Tang JT: Antitumor effect and immune response induced by local hyperthermia in B16 murine melanoma: Effect of thermal dose. Oncol Lett 4: 711-718, 2012.
25. Brown DC and Gatter KC: Ki67 protein: the immaculate deception? Histopathology 40: 2-11, 2002.
26. Lopez F, Belloc F, Lacombe F, Dumain P, Reiffers J, Bernard P and Boisseau MR: Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry 12: 42-49, 1991.
27. Prayson RA: The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms. Adv Anat Pathol 12: 144-148, 2005.